Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-032273

Senior Vice President and CFO sold 10,856 shares at an average $7.84 ($85,090)

  • Senior Vice President and CFO acquired 10,856 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-02 Exercise or conversion : show line 1 in the form +7,356 $3.22 $23,686 144,739 D
2018-11-02 Sale : show line 2 in the form −7,356 $7.78 $57,230 137,383 D
2018-11-02 Exercise or conversion : show line 3 in the form +3,500 $3.78 $13,230 140,883 D
2018-11-02 Sale : show line 4 in the form −3,500 $7.96 $27,860 137,383 D
Open-market sales · 10,856 sh · avg $7.84 · $85,090

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-11-02 Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) −7,356 115,571 D
2018-11-02 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −3,500 45,805 D
Loading xslF345X03/form4.xml…